As a result of vast global improvement of health care and living conditions, the world population is aging. In developed countries, more than half of the cancers occur in patients aged 70 and older. In booming Asian nations, such as India, the aging trend is particularly striking, and therefore geriatric oncology is rapidly coming at the foreground of oncology practice. As these patients have special needs and a different approach to treatment, there is a strong need for the emergence of geriatric oncology as a sub specialty in oncology. Scientific data show that a geriatric assessment identifies many problems in older people with cancer, adds prognostic information, and might improve the outcomes of these patients. There is a genuine unmet requirement to design and implement the following: development of individually tailored geriatric assessment tools for different oncology centers; cooperation of aging and cancer research in the understanding of cancer biology, aging and physiology; improved clinical study designs; development of geriatric oncology programs; and screening tools for geriatric patients made accessible to family physicians.
Introduction
Due to improvement in public health, now more individuals are living longer and the proportion of those living beyond 60 years has increased significantly and will increase further over the next 20 years. It is projected that by 2020, the population of elderly globally would be more than 700 million with two-third belonging to the developing countries [1] [2] . Advancing age is a high risk factor for cancer, with persons over 65 accounting for 60% of newly diagnosed malignancies and 70% of all cancer deaths, mainly prostate, bladder, colon, uterus, pancreas, stomach, rectum, and lung carcinomas [1] [3] [4] . Most countries are experiencing an increase in older individuals with cancer, both in terms of absolute numbers and as a proportion of the total population. The incidence of cancer in those over 65 is 10 times greater than in those younger than 65 and the cancer death rate is 16 times greater in patients over 65 compared to younger patients [3] [5] .
This graying of the population and increasing prevalence of cancer amongst elderly will have important dermographic and socioeconomic consequences. It will profoundly impact the health care industry as more resources and personnel will be required to take care for the elderly. Moreover, this group is less extensively investigated and probably receives less appropriate treatment than younger patients. Usually, the elderly cancer patients are considered not suitable for a curative treatment approach. The choice of treatment modalities in term of radiotherapy, chemotherapy, or even surgery becomes a difficult decision both for the doctor and patients and their relatives. More often elderly patients are put on conservative or less aggressive treatments. Thus, a large proportion of patients are denied the benefit of aggressive treatment. Moreover, many of the prospective clinical trials have excluded this group of patients from the trials, and thus, no worthwhile clinical studies were forthcoming from this age group, especially in developing countries [6] [7] . Therefore, there seems to be a need to integrate and optimize treatment planning for elderly cancer patients to achieve an improved tumor control, quality of life, and survival with better health care [5] [8]- [10] . There is an important role for education of healthcare providers, the elderly and their caregivers to eliminate age bias, institute best practices for screening and prevention and achieve optimal care for older patients with cancer [11] - [16] . The aim of this article is to highlight issues unique to the older adult population and to propose a roadmap for care of such cancer patients.
Physiology of Aging
Some of the reasons why cancer is more common in the elderly include telomere shortening and defective deoxyribo nucleic acid (DNA) repair mechanisms, age-related alterations in the immune system, accumulation of random genetic mutations leading to oncogene activation, amplification or decreased tumor suppressor gene activity, life-time carcinogen exposure, and hormonal alterations or exposure. For the proper management of these patients, a better understanding of the physiology of aging is required. In geriatric age group, there is increase in the body fat and decreased total body water and muscle mass secondary to hormone dysfunction and decreased protein synthesis, loss of sweat glands, decreased gastrointestinal motility and absorption, and decreased hepatic and renal functions. There is decrease in weight of the brain and also there is a decline in the amount of neurotransmitters with age. There is also immunologic dysregulation and compromised marrow reserve. Aging is associated with a progressive decline in the functional reserve of multiple organ systems. This may influence pharmacokinetics and pharmacodynamics of antineoplastic drugs and reduce the tolerance of normal tissues for treatment complications. Age may be construed as a progressive loss of stress tolerance, due to decline in functional reserve of multiple organ systems, high prevalence of comorbid conditions, limited socioeconomic support, reduced cognition, and higher prevalence of depression. Aging is highly individualized; chronologic age may not reflect the functional reserve and life expectancy of an individual [5] [17]- [19] .
Challenges Posed by Multiple Comorbidities
Older people are more likely to have comorbidities and geriatric syndromes such as incontinence, falls, functional decline, polypharmacy and delirium [20] [21] . The strategies to prevent, screen or treat cancer in older individuals will potentially be impacted by these comorbidities. Physical, cognitive, or emotional issues add to the complexity of their care needs. The typical goals of cancer care are influenced by the confluence of health and social issues experienced by older adults, with an emphasis on quality of life playing a critical role in determining which treatments they are willing to accept. Available evidence suggests that the majority of chronically ill older adults value improving or maintaining function more than prolonging life. Quality in cancer care mandates partnering with older adults to enable them to anticipate changing health needs, incorporate their preferences into plans of care, and consistently act based on their individual goals. Ensuring that high-quality services such as palliative care or hospice are available in a timely manner also is essential to addressing this challenge.
Because many older adults face myriad health issues, care is often provided by a diverse and fragmented group of clinicians. Substantial adjustments in the current model of care delivery are required to ensure that the care of older adults with cancer is well coordinated and comprehensive, while also focusing on individuals' goals and preferences [5] [20]- [24] .
Factors Affecting Cancer Treatment Decisions
Decisions about cancer treatment in the older person should be made in the same way that decisions about cancer treatment are made for younger adults and should not focus on the person's age alone. Treatment discussions and decisions, made between the health care team and the older adult with cancer and their family, should be based on but not limited to the following factors [8] which may cause them to refuse procedures or treatment due to cost.
• Spiritual beliefs, as many older adults have already come to terms with death and dying due to chronic illnesses, the loss of a spouse, or advanced age.
Comprehensive Geriatric Assessment (CGA)
The assessment of these patients requires a different approach and comprehensive geriatric assessment (CGA) is recommended for older patients with cancer, which best accounts for the diversities in the geriatric population. The CGA may be defined as a multidisciplinary evaluation in which the multiple problems of older persons are uncovered, described, and explained, if possible, and in which the resources and strengths of the person are catalogued, need for services assessed, and a coordinated care plan developed. This adds information to the presently used measures of functional status in oncology, such as the Karnofsky or Eastern Cooperative Oncology Group Performance Status. The CGA has been designed by geriatricians as a multidimensional assessment of general health status based on validated geriatric scales and tests that produce an inventory of health problems, allowing the development of an individualized geriatric intervention program [5] [10] [17] [26]- [28] . The core components of the CGA are functional status, cognition, mood and emotional status, social support, financial concerns, nutritional status, comorbidities and polypharmacy, geriatric syndromes (fall risk, confusion, urinary incontinence, visual or hearing impairments), goals of care, and advance care planning. The content of the assessment varies with the care setting (e.g., home, clinic, hospital, or nursing home). In many settings, the CGA process relies on a core team consisting of a physician, a nurse, and a social worker, who obtain assistance as needed from other health care professionals (e.g., nutritionist, physical therapist, and/or psychologist). The advantages of the CGA include: 1) Recognition of potentially treatable conditions such as depression or malnutrition, which may lessen the tolerance of cancer treatment and be reversed with proper intervention; 2) Assessment of individual functional reserve; 3) Gross estimate of individual life expectancy; 4) Adoption of a common language to classify older cancer patients. Limitations to the widespread use of the CGA in everyday practice are the considerable time and human resources needed to conduct the assessment and the failure of some health insurance systems to reimburse it [5] 
Lack of Clinical Data in Gertiatric Patients
Responses to cancer diagnoses and treatments are influenced by the aging process. To provide quality cancer care for older adults, research in this population needs to be enhanced. Although the majority of patients with cancer and cancer survivors are older adults, historically they have been and continue to be underrepresented in all types of cancer trials [7] [32]. This may be because many older patients present in advanced stage and have poor physical condition. It may also be due to reluctance on the part of the physicians or patients to enroll in adjuvant trials. Therefore, fewer data are available for assessing the risks and benefits of cancer treatments that carry the possibility of adverse effects and functional decline. Furthermore, chronological age does not automatically equate with functional age. For health care professionals to extrapolate study results to patients seen in general practice, a more detailed characterization of the study population is needed, such as could be captured by a geriatric assessment that provides measures of functional rather than chronological age. This would expand the breadth and depth of data available for understanding the characteristics of patients who may benefit from treatment as well as for developing interventions for those vulnerable to adverse effects. For patients and physicians to adequately balance the risks and benefits of therapy, it is recommended that the research studies include a plan to recruit a population that represents the age distribution and health-risk profiles of patients with cancer [6] [33]- [37] .
Need of Dedicated Geriatric Care Providing Team
Although the number of patients with cancer has increased and the majority of these individuals are older adults, there is a professional workforce shortage of oncologists, geriatricians, and members of the multidisciplinary care team who have expertise in geriatrics. Every country should have a national workforce commission to plan for the challenges of an aging population and the complexity of care required by older adults with cancer [8] [15] [38] . A workforce needs to be developed that understands and values the contributions of the multidisciplinary team and has the knowledge of geriatrics principles essential to support older adults coping with cancer. Therefore, training in geriatrics principles should be included among the core competencies of all individuals caring for older adults [39] [40] .
The increase in the number of older adults, the association of cancer with aging, the workforce shortage, and the financial stressors across the health care system and family networks all contribute to a crisis in cancer care that is most pronounced in the older population. Critically appraising the health care system and redefining these challenges as opportunities would help begin charting a new and better course of action that will improve the quality of cancer care for older adults with cancer in the decades to come. Every geriatric oncology system should develop a roadmap to achieve an integrated system that recognizes that cancer care must be viewed within the context of aging. Indeed, addressing the unique needs of an aging population is central to improving the quality of cancer care [15] [16].
Support and Training of Caregivers
The association between cancer and aging will substantially affect health care systems and health care economics, with an adverse effect on those family members regarded as "family caregivers." Most "hands on" care is provided by family and friends who play a key role in the health care infrastructure, providing support and care for older adults with cancer, often with little or no training. The physical, psychological, financial, and emotional tolls borne by caregivers are gradually being recognized; however, few programs prepare and support the caregivers of older adults with cancer. Effective ways to train and support caregivers must be developed. The only way we can develop adequate care for such a huge number of patients is to use a "train the trainer" approach. There is a need to develop a cadre of geriatric oncology specialists, committed to research and teaching in this particular field. Geriatric oncology specialists will train their geriatrics and oncology colleagues, who in turn will form trained teams in their institutions. These local institution-based teams will train the private practice colleagues in their area. Institutions and private practices will need to develop multidisciplinary structures to treat what already is and increasingly will be a major part of their patients. It is estimated right now that in tertiary centers half of the older cancer patients are in need of a comprehensive oncogeriatric approach. These structures will need to include not only oncologists and geriatricians, but also a team of social workers, dieticians, physical therapists, pharmacists, nurses and mid-level practitioners with knowledge pertaining to this patient population [38] [39] [41] .
Recommendations
• Cancer treatment recommendations and assumptions about elderly patients should not be based solely on their date of birth. Early and appropriate assessments should be used to indicate who will tolerate what treatment. The assessment should not only inform a dialogue about cancer treatment, but should identify and address unmet physical, psychological and social support needs [8] [17] .
• Patients' other health problems and existing medications should be better addressed to ensure they get the maximum benefit from their cancer treatment, ideally with guidance from an elderly care physician.
• Patients should be provided with information about local services which can offer practical and social support during cancer treatment. An older person should never refuse treatment because they are having difficulties with transport or caring for a relative [13] [15].
• More elderly people should have the opportunity to enroll on clinical trials; other forms of evidence need to be gathered to build a solid evidence base.
• More research should be carried out to understand the extent of under treatment and the factors contributing to it.
• More elderly care specialists should be engaged as an active part of the cancer care team and adopt a multidisciplinary approach to the assessment and management of all patients [13] 
Conclusion
In summary, the number of older people with cancer is expected to significantly increase because of the overall aging of the population and the fact that cancer incidence and mortality rise exponentially in the 50 -85 years old age groups. The increased caseload of older patients with cancer will present great challenges to all components of the health care systems. As a result, there is a great need for clinical research to identify and implement evidence-based, personalized, best practices to eliminate pain and suffering from cancer in older patients, enhance their quality of life and extend their meaningful survival. There is considerable heterogeneity among patients of the same age, so that chronologic age alone provides little information regarding an individual's tolerance to cancer treatments. Geriatric oncology is going to become a major component of oncology and geriatric practice, and therefore appropriate consideration and support to it will need to be developed in public health, institutional and educative policies around the world.
